We are live on
!
Find out more
OM
Opaleye Management Portfolio holdings
AUM
$758M
1-Year Est. Return
124.8%
This Fund
S&P 500
This Quarter
Est. Return
+13.93%
1 Year Est. Return
+124.8%
3 Year Est. Return
+486.05%
5 Year Est. Return
+742.19%
10 Year Est. Return
+62,231.09%
AUM
$494M
AUM Growth
+$45M
(+10%)
Cap. Flow
+$16.8M
Cap. Flow
% of AUM
3.4%
Top 10 Holdings %
Top 10 Hldgs %
73.47%
Holding
50
New
5
Increased
15
Reduced
12
Closed
9
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
+$21.3M |
| 2 |
Codexis
CDXS
|
+$7.27M |
| 3 |
Larimar Therapeutics
LRMR
|
+$5.08M |
| 4 |
Disc Medicine
IRON
|
+$4.76M |
| 5 |
VIGL
Vigil Neuroscience
VIGL
|
+$4.48M |
Top Sells
| 1 |
Ginkgo Bioworks
DNA
|
+$5.38M |
| 2 |
PVLA
Palvella Therapeutics
PVLA
|
+$4.82M |
| 3 |
AnaptysBio
ANAB
|
+$4.66M |
| 4 |
SLRN
ACELYRIN
SLRN
|
+$3.99M |
| 5 |
Protara Therapeutics
TARA
|
+$3.02M |
Sector Composition
| 1 | Healthcare | 97.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRGX
26
DELISTED
CARGO Therapeutics
CRGX
| $2.75M | 0.56% |
666,503
| – | – |
|
|
MBX
27
MBX Biosciences
MBX
$2.69B
| $2.73M | 0.55% |
239,319
-10,681
| -4% | -$109K |
|
28
Zymeworks
ZYME
$1.81B
| $2.64M | 0.53% |
210,000
+35,000
| +20% | +$417K |
|
|
29
Protara Therapeutics
TARA
$230M
| $2.59M | 0.52% |
855,000
-875,000
| -51% | -$3.02M |
|
|
ALMS
30
Alumis Inc
ALMS
$3.48B
| $2.33M | 0.47% |
+775,000
| New | +$3.66M |
|
31
Zentalis Pharmaceuticals
ZNTL
$340M
| $2.23M | 0.45% |
1,924,300
-60,700
| -3% | -$80.1K |
|
32
Trevi Therapeutics
TRVI
$2.54B
| $2.13M | 0.43% |
390,000
-405,000
| -51% | -$2.52M |
|
33
Avita Medical
RCEL
$124M
| $2.06M | 0.42% |
389,519
-50,481
| -11% | -$367K |
|
|
IRD
34
Opus Genetics
IRD
$294M
| $1.15M | 0.23% |
1,220,000
+45,000
| +4% | +$41.7K |
|
35
Journey Medical
DERM
$196M
| $682K | 0.14% |
95,000
+25,677
| +37% | +$177K |
|
|
ELEV
36
DELISTED
Elevation Oncology
ELEV
| $529K | 0.11% |
+1,442,061
| New | +$481K |
|
37
iBio
IBIO
$71.5M
| $285K | 0.06% |
375,000
| – | – |
|
38
PepGen
PEPG
$169M
| $266K | 0.05% |
240,000
-180,000
| -43% | -$255K |
|
|
ADGM
39
Adagio Medical Holdings
ADGM
$12.9M
| $144K | 0.03% |
110,571
| – | – |
|
|
40
AnaptysBio
ANAB
$1.85B
| – | – |
-250,933
| Closed | -$4.66M |
|
41
Biodesix
BDSX
$219M
| – | – |
-161,250
| Closed | -$2.02M |
|
42
Kiniksa Pharmaceuticals
KNSA
$4.77B
| – | – |
-62,501
| Closed | -$1.39M |
|
43
Nurix Therapeutics
NRIX
$2.38B
| – | – |
-115,000
| Closed | -$1.37M |
|
|
OPTN
44
DELISTED
OptiNose
OPTN
| – | – |
-193,039
| Closed | -$1.77M |
|
|
SGMO
45
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| – | – |
-1,055,000
| Closed | -$692K |
|
|
SLRN
46
DELISTED
ACELYRIN
SLRN
| – | – |
-1,615,000
| Closed | -$3.99M |
|
|
VTYX
47
DELISTED
Ventyx Biosciences
VTYX
| – | – |
-190,000
| Closed | -$219K |
|
|
PVLA
48
Palvella Therapeutics
PVLA
$2.15B
| – | – |
-172,357
| Closed | -$4.82M |
|
Similar funds
WCFA
SIG
GWM
IAS
TVAMP
RFM
MWA
CFS